decisionhealth Newsletters, Part B News - 2011 Issue 9 (September)
Significant rate changes in CMS’s Q4 ASP drug pricing
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s Q4 Average Sales Price (ASP) drug pricing update for Part B drugs. It is useful for coders, billing staff, and reimbursement analysts who track drug pricing changes, newly added or removed drug codes, and general market shifts affecting outpatient drug reimbursement. The article includes a summary of overall pricing movement, examples of significant increases and decreases, and a table of selected code-level changes.
Why This Topic Matters
ASP pricing updates can affect drug reimbursement analysis, charge review, and revenue forecasting for Medicare Part B services. Knowing which codes were added, removed, or changed significantly helps billing and compliance teams monitor pricing updates and related claims impacts.
Article Sections
-
Drug pricing
Overview of the fourth-quarter ASP pricing update and broad trends in Part B drug reimbursement. Includes general movement in drug prices and context for the largest changes.
-
Key ASP changes for the fourth quarter (Q4) of 2011
Summary table of selected code-level price increases and decreases within the quarterly ASP update. Covers the broad set of drugs highlighted by CMS and the article’s analysis.
What You Will Learn
- How CMS’s quarterly ASP update is presented at a high level
- What kinds of pricing changes were observed across Part B drugs
- Which broad categories of ASP update information the article highlights
- How selected drug codes were categorized as increases or decreases in the report
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Reimbursement analysts
- Practice managers
- Compliance teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com